FHA results from disruption of the HPO axis consequent to other endocrine changes and possibly a genetic predisposition, with an impact on reproductive, neuropsychiatric and skeletal health (summarized in Figure 4). The gene discussed is GFER; the disease is hypoalphalipoproteinemia, primary, 1.